Welcome : Guest

ProMetic Life Sciences, Inc. (Canada) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about ProMetic Life Sciences, Inc., which is principally involved in Biopharmaceuticals Business. Illustrated with 97 tables, the report showcases the company's recent news stories and events, sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-41309
Price: $3500
Company Type: Public
Pages: 100
Date: June 2016
Market Data Tables: 97

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: ProMetic Life Sciences, Inc.’s Sales by Geographic Region Worldwide (2014-2015) in Percentage for Switzerland, USA, Russia, Austria, Netherlands, Taiwan, and Other Countries......3
Table 2: ProMetic Life Sciences, Inc.’s Sales by Source Worldwide (2014-2015) in Percentage for Revenues from the Sale of Goods, Revenues from the Rendering of Services, and Milestone and Licensing Revenues......4
API for Small Molecules......5
Table 3: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2014) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......5
Table 4: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......6
Table 5: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2014) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......7
Diabetes Market......8
Table 6: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type‐1 Diabetes, Insulin Type‐2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP‐1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......8
Table 7: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......9
Table 8: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......10
Table 9: Diabetes/Metabolic Drugs Market by Category Worldwide (2014) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......11
Table 10: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......12
Table 11: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......13
Table 12: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......14
Table 13: No. of Diabetes Patients by Medication in the US (2014) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......15
Table 14: Type 1 Diabetes Market by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Continuous Glucose Monitoring Users, and Non-Continuous Glucose Monitoring Users......16
Table 15: Type 1 Diabetes Market by Medical Device in the US (2015) - Percentage Share Breakdown by Value for Insulin Pumps and Multiple Daily Injections......17
Anti-Diabetic Drugs......18
Table 16: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......18
Table 17: Anti-Diabetic Drug Market by Treatment Class Worldwide (2014) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......19
Table 18: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......20
Table 19: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......21
Biological Drugs......22
Table 20: Biological Drugs Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Daratumuma, Elotuzumab, MOR202 and SAR650984......22
Table 21: Therapeutic Biologics Market by Type in China (2014) - Percentage Share Breakdown by Value for Erythropoietin (EPO), Granulocyte Colony-Stimulating Factor (GCSF), Insulin, Interferon, Interleukin, Monoclonal Antibodies (MAb), Nerve GF, Somatropin, and Others......23
Table 22: Biologics Therapeutic Classes Market by Category in China (2014) - Percentage Share Breakdown by Value for Cardiovascular, CNS, Dermatology, Hematology, Metabolic, Musculoskeletal, Oncology, Urinary, and Others......24
Cancer Market......25
Table 23: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......25
Table 24: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......26
Table 25: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......27
Table 26: Cancer Care Expenditure by Site Worldwide (2014) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others......28
Table 27: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......29
Table 28: Skin Cancer by Type Worldwide (2014) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......30
Table 29: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......31
Table 30: Hematological Cancer by Category Worldwide (2014) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......32
Table 31: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......33
Table 32: No. of Bladder Cancer Patients by Category in the US (2014) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......34
Table 33: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......35
Table 34: No. of Cancer Patients Death by Type in the US (2014) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......36
Table 35: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......37
Table 36: No. of Solid Cancer Tumor Patients by Type Worldwide (2014) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......38
Table 37: Number of Cancer Patients by Type in the US (2014) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......39
Table 38: Number of Cancer Patients by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......40
Anti-Cancer Drugs......41
Table 39: Anti-Cancer Drugs Market by Product Type in China (2014) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......41
Table 40: Anti-Cancer Drugs Market by Type in China (2014) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......42
Chronic Kidney Disease Drugs......43
Table 41: Traditional Chinese Medicine (TCM) Market for Kidney Ailments by Drug in China (2014) - Percentage Share Breakdown by Value Sales for Ambrette Capsule, Haikunshenxi Capsule, Shenyankangfu Tablet, Uremic Clearance Granule, Yinhuamiyangling and Others......43
Table 42: Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......44
Table 43: Chronic Kidney Disease Market by Drug in the US (2014) - Percentage Share Breakdown by Value Sales for Aranesp and Others......45
Clinical Trials......46
Table 44: Clinical Trials by Region Worldwide (2014) - Percentage Market Share Breakdown by Value for Africa, Asia, Australia, Canada, Europe, Mexico, South America, and United States......46
Cystic Fibrosis (CF)......47
Table 45: Cystic Fibrosis (CF) Patient Population by Region Worldwide (2014) - Percentage Share Breakdown by Value for Australia, Canada, Rest of Europe, United Kingdom and USA......47
Table 46: Molecular Cystic Fibrosis (CF) Testing Market by Assay in the US (2014) - Percentage Share Breakdown by Value Sales for Cystic Fibrosis Genotyping, eSensor® Cystic Fibrosis, InPlex® Cystic Fibrosis (CF), Laboratory Developed Tests and xTAG® Cystic Fibrosis......48
Immunology......49
Table 47: Immune Tolerance Therapy (Patient) Treatment for Hemophilia A Patients by Category Worldwide (2014) - Percentage Market Share Breakdown by Value for 0-12, 13-21 and 22+......49
Table 48: Immunology Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Dermatology, Gastroenterology, and Rheumatology......50
Table 49: Immunostimulants Market by Type Worldwide (2014) - Percentage Share Breakdown by Value for Interferon α-2a, Lentinan, RhG-CSF, Thymopentin, Thymosin α1, and Others......51
Oncology......52
Table 50: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......52
Table 51: Oncology Genomics (Clinical, Hereditary, and Molecular Monitoring) Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......53
Table 52: Hereditary Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......54
Table 53: Oncology Genomics Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......55
Table 54: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......56
Table 55: Oncology Market by Product Segment Worldwide (2014) - Percentage Breakdown by Value for Dialysis Catheters, Enteral Feeding, Peripherally Inserted Central Catheters, Ports, Ultrasound, and Others......57
Table 56: Oncology/Hematology Drugs Market by Category Worldwide (2014) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......58
Table 57: Clinical Oncology Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for US, and Others......59
Table 58: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......60
Table 59: Oncology Genomics Market by Category in the US (2014) - Percentage Share Breakdown by Value Sales for Clinical, Hereditary, and Molecular Monitoring......61
Table 60: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......62
Plasma Market......63
Table 61: Plasma Market by Product Worldwide (2015) - Percentage Breakdown by Value for Albumin, Factor IX, Factor VIII, Hyperimmunes, Intravenous Immunoglobulin (IVIG), and Others......63
Table 62: Plasma Market by Products (excluding Recombinant Factors) Worldwide (2015) - Percentage Share Breakdown by Value for Albumin, Factor VIII, Intravenous Immunoglobulin (IVIG) and Others......64
Table 63: Plasma Market by Region (excluding Recombinant Factors) Worldwide (2015) - Percentage Share Breakdown by Value for Asia-Pacific, Europe, North America and Others......65
Table 64: Plasma Market by Region Worldwide (2014) - Percentage Share Breakdown by Value Sales for Asia, Europe, and Middle East, USA, and Others......66
Table 65: Plasma Market by Segment in China (2014) - Percentage Share Breakdown by Value for Alpha-1 proteinase inhibitor (A1PI), Coagulation Factor IX, Coagulation Factor VIII, Fibrinogen, Human Albumin, Immunoglobulin for Intramuscular Injection, Intravenous Immunoglobulin (IVIG), Prothrombin Complex, and Specific Immunoglobulin......67
Table 66: Plasma Products Consumption by Type in China (2014) - Percentage Share Breakdown by Volume for Albumin, Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG)......68
Table 67: Plasma-Based Product Market by Type in China (2014) - Percentage Share Breakdown by Value for Blood Coagulation Factor, Human Albumin, Human Immunoglobin, Hyperimmunes, and Others......69
Table 68: Plasma Products Consumption by Type in the US (2014) - Percentage Share Breakdown by Volume for Albumin, Factor IX (Plasma), Factor VIII, Hyperimmunes (IM&IV), and Intravenous Immunoglobulin (IVIG), and Others......70
Plasma Proteins......71
Table 69: Plasma Proteins Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Albumin, Globulins and Others......71
Table 70: Plasma Proteins Market by Region Worldwide (2014) - Percentage Share Breakdown by Value for Africa, Asia-Pacific, Europe, Middle East, North America, Oceania, and South America......72
Plasma Derivatives......73
Table 71: Plasma-Derived Therapeutic Demand by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Europe, USA, and Rest of World......73
Table 72: Plasma Derivatives Market by Region Worldwide (2014) - Percentage Share Breakdown by Value for Europe, North America, and Others......74
Table 73: Plasma Derivatives Market by Segment Worldwide (2014) - Percentage Share Breakdown by Value for Albumin, Alpha-1 Proteinase Inhibitor (A1PI), Hyperimmune, Intravenous Immunoglobulin (IVIG), Plasma-Derived Factor VIII (PDFVIII) & Willebrand Factor (WFactor), Polymeric Immunoglobulin Receptor, and Others......75
Table 74: No. of Biologics in Development by Therapeutic Area Worldwide (2014) - Percentage Market Share Breakdown for Autoimmune Disorders, Blood Disorders, Cancer/ Related Conditions, Cardiovascular Disease, Diabetes/Related Conditions, Digestive Disorders, Eye Conditions, Genetic Disorders, Infectious Diseases, Musculoskeletal Disorders, Neurologic Disorders, Respiratory Disorders, Skin Diseases, Transplantation, and Others......76
Pathogen Testing......77
Table 75: Pathogen Testing Market by Category in North America (2014) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Molecular, and Traditional......77
Table 76: Pathogen Testing Market by Segment Worldwide (2014) - Percentage Share Breakdown by Volume for Escherichia Coli, Listeria, Salmonella, and Others......78
Table 77: Pathogen Testing Market by Type Worldwide (2014) - Percentage Share Breakdown by Volume for Culture, Immunochemical, and Molecular......79
Table 78: Pathogen Testing Market by Category in Asia (2014) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Convenience, Molecular, and Traditional......80
Table 79: Pathogen Testing Market by Category in European Union (EU) (2014) - Percentage Share Breakdown by Volume for Antibody, Chromogenic, Molecular, and Traditional......81
Diabetes/Metabolic Therapeutics......82
Table 80: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......82
Table 81: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......83
Anti-Diabetics......84
Table 82: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......84
Breast Cancer Drugs......85
Table 83: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......85
Chemotherapy-Induced Thrombocytopenia (CIT)......86
Table 84: Market Shares of Leading Drugs for the Treatment of Chemotherapy-Induced Thrombocytopenia (CIT) in China (2015) - Percentage Share Breakdown by Value for Baijieyi, Juheli, Recombinant Human Thrombopoietin, Te Er Kang and Others......86
Immunology/ Immunoglobulin (IG)......87
Table 85: Market Shares of Leading Immunology/ Immunoglobulin Providers in the US (2015) - Percentage Breakdown by Value for Baxter International Inc., CSL Limited, Grifols, S.A., and Others......87
Oncology Drugs......88
Table 86: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......88
Table 87: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......89
Table 88: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......90
Orphan Disease Therapeutics......91
Table 89: Market Shares of Leading Orphan Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Pfizer, Inc., Sanofi S.A., and Others......91
Pathogen Testing......92
Table 90: Market Shares of Leading Pathogen Testing Equipment Brands Worldwide (2014) - Percentage Share Breakdown by Value for 3M Petrifilm, BioMerieux VIDAS, DuPont BAX, and Others......92
Plasma Market......93
Table 91: Market Shares of Leading Plasma Companies Worldwide (2015) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL Limited, Grifols, S.A. and Others......93
Table 92: Market Shares of Leading Plasma Treatment Companies Worldwide (2015) - Percentage Share Breakdown by Value for Applied Materials, Inc., Hitachi Kokusai Electric Inc., Tokyo Electron Limited and Others......94
Table 93: Market Shares of Leading Plasma Companies in China (2014) - Percentage Share Breakdown by Volume for Chengdu Rongsheng Pharmaceuticals Co., Ltd., China Biologic Products, Inc., Hualan Biological Engineering, Inc., Shanxi Kangbao Biological Product Co., Ltd., Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd., Tonglu Biological Pharmaceutical Co., Ltd., and Others......95
Table 94: Market Shares of Leading Plasma Companies in the US (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL Behring, Octapharma AG, Talecris Plasma Resources (Grifols, Inc.), and Others......96
Plasma Derivatives......97
Table 95: Market Shares of Leading Plasma Derivative Companies Worldwide (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL, Ltd., Grilfols USA, Kedrion Biopharma, LFB, Octapharma AG, and Others......97
Table 96: Market Shares of Leading Plasma Derivative Companies in the US (2014) - Percentage Share Breakdown by Value for Baxter International, Inc., CSL, Ltd., Grilfols USA, and Octapharma AG......98
Plasma Proteins......99
Table 97: Market Shares of Leading Plasma Protein Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Baxter International, Inc., Biotest Pharmaceuticals Corporation, CSL Ltd., Grifols, S.A., Octapharma AG, and Others......99